Purification and long-term expansion of multipotent endothelial-like cells with potential cardiovascular regeneration

Stem Cells and Development

Volumn 21, Issue 4, 2012, Pages 562-574

  Marchal, Juan A ^a,b   Picón, Manuel ^a,b   Perán, MacArena ^a,c   Bueno, Clara ^a   Jiménez Navarro, Manuel ^d   Carrillo, Esmeralda ^a,b   Boulaiz, Houria ^a,b   Rodríguez, Noela ^d   Álvarez, Pablo ^a   Menendez, Pablo ^a   De Teresa, Eduardo ^d   Aránega, Antonia ^a,b  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF JAÉN   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ANGIOPOIETIN RECEPTOR; BETA ACTIN; CD133 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; COLLAGEN TYPE 4; CYCLIN DEPENDENT KINASE 2; DLL4 PROTEIN; ENDOGLIN; MATRIGEL; PROTEIN; STROMAL CELL DERIVED FACTOR 1; THY 1 ANTIGEN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ARTICLE; CARDIOVASCULAR REGENERATION; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIAL PROGENITOR CELL; GENE EXPRESSION PROFILING; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTIPOTENT ENDOTHELIAL LIKE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL EXPANSION; SUBCUTANEOUS FAT; TISSUE REGENERATION;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, DIFFERENTIATION; CARDIOVASCULAR DISEASES; CATTLE; CELL SEPARATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MULTIPOTENT STEM CELLS; REGENERATIVE MEDICINE;

BOVINAE;

EID: 84857483851     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0072     Document Type: Article

References (48)

1. S Kim and von Recum H. (2008). Endothelial stem cells and precursors for tissue engineering: cell source, differentiation, selection, and application. Tissue Eng Part B Rev 14:133-147.
2. Campioni D, A Lo Monaco, F Lanza, S Moretti, L Ferrari, M Fotinidi, R La Corte, A Cuneo and F Trotta. (2008). CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis. Haematologica 93:1233-1237.
3. Krenning G, BW van der Strate, M Schipper, XJ van Seijen, BC Fernandes, MJ van Luyn and MC Harmsen. (2009). CD34+ cells augment endothelial cell differentiation of CD14+ endothelial progenitor cells in vitro. J Cell Mol Med 13:2521-2533.
4. Igreja C, R Fragoso, F Caiado, N Clode, A Henriques, L Camargo, EM Reis and S Dias. (2008). Detailed molecular characterization of cord blood-derived endothelial progeni-tors. Exp Hematol 36:193-203.
5. Taljaard M, MR Ward, MJ Kutryk, DW Courtman, NJ Ca-mack, SG Goodman, TG Parker, AJ Dick, J Galipeau and DJ Stewart. (2010). Rationale and design of Enhanced Angio-genic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): the first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial in-farction. Am Heart J 159:354-360.
6. Tateishi-Yuyama E, H Matsubara, T Murohara, U Ikeda, S Shintani, H Masaki, K Amano, Y Kishimoto, K Yoshimoto, H Akashi, K Shimada, T Iwasaka and T Imaizumi. Ther-apeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. (2002). Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised con-trolled trial. Lancet 360:427-435.
7. Dzau VJ, M Gnecchi, AS Pachori, F Morello and LG Melo. (2005). Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension 46:7-18. (Pubitemid 40946479)
8. Iwashima S, T Ozaki, S Maruyama, Y Saka, M Kobori, K Omae, H Yamaguchi, T Niimi, K Toriyama, Y Kamei, S Torii, T Murohara, Y Yuzawa, Y Kitagawa and S Matsuo. (2009). Novel culture system of mesenchymal stromal cells from human subcutaneous adipose tissue. Stem Cells Dev 18:533-543.
9. Foresta C, L De Toni, A Ferlin and A Di Mambro. (2010). Clinical implication of endothelial progenitor cells. Expert Rev Mol Diagn 10:89-105.
10. Jin XB, YS Sun, K Zhang, J Wang, XD Ju and SQ Lou. (2007). Neocartilage formation from predifferentiated human adi-pose derived stem cells in vivo. Acta Pharmacol Sin 28:663-671. (Pubitemid 46684018)
11. Rodr?́guez-Serrano F, P Alvarez, O Caba, M Picón, JA Marchal, M Perán, J Prados, C Melguizo, AR Rama, H Boulaiz and A Aránega. (2010). Promotion of human adipose-derived stem cell proliferation mediated by exoge-nous nucleosides. Cell Biol Int 34:917-924.
12. Perán M, JA Marchal, E López, M Jiménez-Navarro, H Boulaiz, F Rodŕ?guez-Serrano, E Carrillo, G Sánchez-Espin, E de Teresa, D Tosh and A Aranega. (2010). Human cardiac tissue induces transdifferentiation of adult stem cells to-wards cardiomyocytes. Cytotherapy 12:332-337
13. Rubio R, J Garća-Castro, I Gutiérrez-Aranda, J Paramio, M Santos, P Catalina, PE Leone, P Menendez and R Rodŕguez. (2010). Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and ini-tiates leiomyosarcoma in vivo. Cancer Res 70:4185-4194.
14. Hirashima M, M Ogawa, S Nishikawa, K Matsumura, K Kawasaki, M Shibuya and S Nishikawa. (2003). A chemi-cally defined culture of VEGFR2+ cells derived from em-bryonic stem cells reveals the role of VEGFR1 in tuning the threshold for VEGF in developing endothelial cells. Blood 101:2261-2267 (Pubitemid 36302068)
15. Menéndez P, JA Pérez-Simón, MV Mateos, MD Caballero, M González, San-Miguel JF and A Orfao. (2002). Influence of the different CD34+ and CD34- cell subsets infused on clinical outcome after non-myeloablative allogeneic periph-eral blood transplantation from human leucocyte antigen-identical sibling donors. Br J Haematol 119:135-143. (Pubitemid 35176513)
16. Montes R, G Ligero, L Sanchez, P Catalina, T de la Cueva, A Nieto, GJ Melen, R Rubio, J Garć?a-Castro, C Bueno and P Menendez. (2009). Feeder-free maintenance of hESCs in mesenchymal stem cell-conditioned media: distinct require-ments for TGF-beta and IGF-II. Cell Res 19:698-709.
17. Ramos-Mejia V, GJ Melen, L Sanchez, Gutierrez-Aranda I, G Ligero, JL Cortes, PJ Real, C Bueno and P Menendez. (2010). Nodal/activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage. Mol Ther DOI:10.1038/mt.2010.179
18. Catalina P, C Bueno, R Montes, A Nieto, G Ligero, L San-chez, M Jara, A Rasillo, A Orfao, J Cigudosa, O Hovatta, M Greaves and P Menendez. (2009). Genetic stability of human embryonic stem cells: A first-step toward the development of potential hESC-based systems for modeling childhood leukemia. Leuk Res 33:980-990.
19. Soares R, G Balogh, S Guo, F Gartner, J Russo and F Schmitt. (2004). Evidence for the notch signaling pathway on the role of estrogen in angiogenesis. Mol Endocrinol 18:2333-2343. (Pubitemid 39215261)
20. Lopes FC, A Rocha, A Pirraco, LO Regasini, DH Silva, VS Bolzani, I Azevedo, IZ Carlos and R Soares. (2009). Anti-angiogenic effects of pterogynidine alkaloid isolated from Alchornea glandulosa. BMC Complement Altern Med 9:15.
21. Ingram DA, LE Mead, H Tanaka, V Meade, A Fenoglio, K Mortell, K Pollok, MJ Ferkowicz, D Gilley and MC Yoder. (2004). Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104:2752-2760. (Pubitemid 39434958)
22. Dai W, SL Hale, BJ Martin, JQ Kuang, JS Dow, LE Wold and RA Kloner. (2005). Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112:214-223. (Pubitemid 40982304)
23. Madonna R and R De Caterina. (2010). Adipose tissue: a new source for cardiovascular repair. J Cardiovasc Med (Hagerstown) 11:71-80.
24. Bayes-Genis A, C Soler-Botija, J Farré, P Sepúlveda, A Raya, S Roura, C Prat-Vidal, C Gálvez-Montón, JA Montero, D Büscher and JC Belmonte. (2010). Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. J Mol Cell Cardiol 49:771-780.
25. Chen MY, PC Lie, ZL Li and X Wei. (2009). Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mes-enchymal stem cells 7:629-640.
26. Mart́?nez-Estrada OM, Y Muñoz-Santos, J Julve, M Reina and S Vilaró. (2005). Human adipose tissue as a source of Flk-1 + cells: new method of differentiation and expansion. Cardiovasc Res 65:328-333. (Pubitemid 40082474)
27. Prasad Chennazhy K and LK Krishnan. (2005). Effect of passage number and matrix characteristics on differentiation of endothelial cells cultured for tissue engineering. Bioma-terials 26:5658-5667 (Pubitemid 40616836)
28. Marchal JA, H Boulaiz, M Peran, J Prados, J Campos, F González, F Rodŕ?guez-Serrano, C Melguizo, C Vélez, E Carrillo, F Hita, R Ortiz, A Mart́?nez-Amat, O Caba, C Ventura and A Aránega. Eds. (2009). Therapeutic Potential of Differentiation in Cancer and Normal Stem Cells. Nova Science Publishers, Inc., New York.
29. Peichev M, AJ Naiyer, D Pereira, Z Zhu, WJ Lane, M Wil-liams, MC Oz, DJ Hicklin, L Witte, MA Moore and S Rafii. (2000). Expression of VEGFR-2 and AC133 by circulating human CD34( + ) cells identifies a population of functional endothelial precursors. Blood 95:952-958. (Pubitemid 30062717)
30. Wang L, Li L, F Shojaei, C Cerdan, P Menendez, T Martin, A Rouleau and M Bhatia. (2004). Endothelial and hematopoi-etic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 21:31-41. (Pubitemid 38925265)
31. Suga H, D Matsumoto, H Eto, K Inoue, N Aoi, H Kato, J Araki and K Yoshimura. (2009). Functional Implications of CD34 Expression in Human Adipose-Derived Stem/ Progenitor Cells. Stem Cells Dev 18:1201-1210.
32. Howson KM, AC Aplin, M Gelati, G Alessandri, Parati EA and RF Nicosia. (2005). The postnatal rat aorta contains pericyte progenitor cells that form spheroidal colonies in suspension culture. Am J Physiol Cell Physiol 289:1396-1407.
33. Landerholm TE, XR Dong, J Lu, NS Belaguli, RJ Schwartz and MW Majesky. (1999). A role for serum response factor in coronary smooth muscle differentiation from proepicardial cells. Development 126:2053-2062. (Pubitemid 29271691)
34. Campioni D, F Lanza, S Moretti, L Ferrari and A Cuneo. (2008). Loss of Thy-1 (CD90) antigen expression on mesen-chymal stromal cells from hematologic malignancies is in-duced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics. Cy-totherapy 10:69-82.
35. Bagley RB, W Weber, C Rouleau and BA Teicher. (2005). Pericytes and Endothelial Precursor Cells: Cellular Interac-tions and Contributions to Malignancy. Cancer Res 65:9741-9750. (Pubitemid 41541451)
36. Furuhata S, K Ando, M Oki, K Aoki, S Ohnishi, K Aoyagi, H Sasaki, H Sakamoto, T Yoshida and S Ohnami. (2007). Gene expression profiles of endothelial progenitor cells by oligo-nucleotide microarray analysis. Mol Cell Biochem 298:125-138. (Pubitemid 46605290)
37. Saharinen P, M Bry and K Alitalo. (2010). How do angio-poietins Tie in with vascular endothelial growth factors? Curr Opin Hematol 17:198-205.
38. Gomei Y, Y Nakamura, H Yoshihara, K Hosokawa, H Iwasaki, T Suda and F Arai. (2010). Functional differences between two Tie2 ligands, angiopoietin-1 and -2, in regula-tion of adult bone marrow hematopoietic stem cells. Exp Hematol 38:82-89.
39. Hogan BM, R Herpers, M Witte, H Heloterä, K Alitalo, HJ Duckers and Schulte-Merker S. (2009). Vegfc/Flt4 signalling is suppressed by Dll4 in developing zebra fish interseg-mental arteries. Development 136:4001-4009.
40. Harrington LS, RC Sainson, CK Williams, JM Taylor, W Shi, JL Li and AL Harris. (2008). Regulation of multiple angio-genic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Microvasc Res 75:144-154. (Pubitemid 351249857)
41. Yamaguchi J, KF Kusano, O Masuo, A Kawamoto, M Silver, S Murasawa, M Bosch-Marce, H Masuda, DW Losordo, JM Isner and T Asahara. (2003). Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell re-cruitment for ischemic neovascularization. Circulation 107:1322-1328. (Pubitemid 36314418)
42. Kondo K, S Shintani, R Shibata, H Murakami, R Murakami, M Imaizumi, Y Kitagawa and T Murohara. (2009). Im-plantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol 29:61-66.
43. Makino S, K Fukuda, S Miyoshi, F Konishi, H Kodama, J Pan, M Sano, T Takahashi, S Hori, H Abe, J Hata, A Umezawa and S Ogawa. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103:697-705. (Pubitemid 29122423)
44. Höllrigl A, M Hofner, M Stary and G Weitzer. (2007). Dif-ferentiation of cardiomyocytes requires functional serine residues within the amino-terminal domain of desmin. Dif-ferentiation 75:616-626. (Pubitemid 47301599)
45. Mohri T, Y Fujio, M Maeda, T Ito, T Iwakura, Y Oshima, Y Uozumi, M Segawa, H Yamamoto, T Kishimoto and J Azuma. (2006). Leukemia inhibitory factor induces endo-thelial differentiation in cardiac stem cells. J Biol Chem 281: 6442-6447. (Pubitemid 43847576)
46. Li SC, J Acevedo, PH Schwartz, L Wang, H Jiang, J Luo, RG Pestell, WG Loudon and AC Chang. (2011). Mechanisms for progenitor cell-mediated repair for ischemic heart injury. Curr Stem Cell Res Ther PMID:2l466480
47. Choi SC, WJ Shim and DS Lim. (2008). Specific monitoring of cardiomyogenic and endothelial differentiation by dual promoter-driven reporter systems in bone marrow mesen-chymal stem cells. Biotechnol Lett 30:835-843.
48. Asahara T, T Murohara, A Sullivan, M Silver, R van der Zee, T Li, B Witzenbichler, G Schatteman and JM Isner. (1997). Isolation of putative progenitor endothelial cells for angio-genesis. Science 275:964-967.